Open original FDA record ↗Recall record
- FDA identifier
- Z-1469-2020
- Company in FDA record
- The Binding Site Group, Ltd.
- FDA record creation date
- Mar 11, 2020
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
A deterioration of performance was identified with influenza type B Enzyme Immunoassay Kits with findings of a positive bias with kit controls. Patient sample results may be affected with falsely elevated results incorrectly indicating a protective level of anti-Hib antibody in the assessment of immunodeficiency.
Source facts
- Action
- On XXX, an Urgent Field Safety Notice was sent via email to customers. Customers are instructed to discontinue using this product immediately; dispose of any remaining product at your facility following local regulations; discuss this information with your medical director so that the potential impact of the issue is considered on a local level; and to return the completed and signed E-Back form TSWS18 to Technical.Support@bindingsite.com or to your local firm representative within one week of receiving this notification. Customers are also requested to include a witness signature for the kit disposal as this is required on the E-Back form. Customers with additional questions were encouraged to email Technical.support@bindingsite.com.
- Initiated
- 2018-08-12
- Root cause
- Under Investigation by firm
- Terminated
- 2022-01-20
- Distribution
- Worldwide distribution - US Nationwide distribution in the states of M.A., C.A., MO., NC, MN, VA, WA, and IL and country of Canada.
- Recall number
- Z-1469-2020
- Recall status
- Terminated
- CDRH record ID
- 179633
- FDA record created
- 2020-03-11
- Recall event number
- 84899